Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01027494 · ClinicalTrials.gov registry record
Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora
A clinical trial, sponsored by Alcon Research.
- Completed
- Registry status
- 318
- Enrollment target
NCT01027494 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 318 participants.
The verdict
NCT01027494 has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 318 participants
- Enrollment target
Study Summary
The purpose of this observational study was to evaluate the effects of a topical fluoroquinolone (antibiotic) instilled into the otic (ear) canal to treat Acute Otitis Media through Tympanostomy Tubes (AOMT) on selected bacterial species on the skin near the ear, in the nose, and in the throat.
Interventions
- DRUG Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01027494
The ClinicalTrials.gov registry entry for NCT01027494 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 318 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension is the first listed.
NCT01027494 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01027494 about?
NCT01027494 is a clinical study titled "Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora". The purpose of this observational study was to evaluate the effects of a topical fluoroquinolone (antibiotic) instilled into the otic (ear) canal to treat Acute Otitis Media through Tympanostomy Tubes (AOMT) on selected bacterial species on the skin near the ear, in the nose, and in the throat.
What is the current status of trial NCT01027494?
This trial is currently completed. The enrollment target is 318 participants. The study started on 2009-12. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01027494?
The interventions under investigation include: Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension (DRUG).
Who is sponsoring clinical trial NCT01027494?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.